Amarin reported 9.73 in PE Price to Earnings for its fiscal quarter ending in December of 2021.


Pe Change Date
AbbVie 18.41 69.26 Jun/2025
Amarin 9.73 14.55 Dec/2021
AstraZeneca 20.04 12.31 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
Halozyme Therapeutics 11.9 5.04 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 42.61 5.9 Jun/2025
Novartis 15.89 3.03 Jun/2025